Device Trial Radar · NCT02927665
A Prospective Multicenter Post Approval Study of the ReShape™ Integrated Dual Balloon System in Obese Subjects
Last checked: Nov 20, 2026Latest source record: Mar 29, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
186
Actual
Start
Sep 2016
Primary completion
Nov 2019
Study completion Dec 2019
Sponsor
- Lead sponsor
- ReShape LifesciencesNot on our public-company list
- Sponsor type
- Industry
- First posted
- Oct 7, 2016
Design
- Study type
- Observational
- Who can join
- All sexes, from 22 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The ReShape Post Approval Study is a prospective multicenter study of the ReShape(TM) Integrated Dual Balloon System in Obese Subjects.
Conditions
- Obesity
Interventions
Reshape Integrated Dual BalloonDevice
Primary outcomes
What the sponsor says the trial is designed to measure.
- Safety of ReShape Dual Balloon TreatmentTime frame: 24 weeks
Locations
14 sites in 1 country. Site status is shown where the registry gives one.
Digestive Health Specialists of the Southeast
Dothan, Alabama
Christiana Institute of Advanced Surgery
Newark, Delaware
Barrington Surgeons
Barrington, Illinois
11 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.